Markus P Schlaich1, Yusuke Sata2, Murray D Esler3. 1. Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia markus.schlaich@bakeridi.edu.au. 2. Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. 3. Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Authors: Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm Journal: Lancet Date: 2010-11-17 Impact factor: 79.321
Authors: Julian F R Paton; Paul A Sobotka; Marat Fudim; Zoar J Engelman; Zoar J Engleman; Emma C J Hart; Fiona D McBryde; Ana P Abdala; Nepthali Marina; Alexander V Gourine; Mel Lobo; Nik Patel; Amy Burchell; Laura Ratcliffe; Angus Nightingale Journal: Hypertension Date: 2012-11-19 Impact factor: 10.190
Authors: L E K Ratcliffe; W Pijacka; F D McBryde; A P Abdala; D J Moraes; P A Sobotka; E C Hart; K Narkiewicz; A K Nightingale; J F R Paton Journal: J Physiol Date: 2014-09-15 Impact factor: 5.182
Authors: Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris Journal: N Engl J Med Date: 2014-03-29 Impact factor: 91.245
Authors: Fiona D McBryde; Ana P Abdala; Emma B Hendy; Wioletta Pijacka; Paul Marvar; Davi J A Moraes; Paul A Sobotka; Julian F R Paton Journal: Nat Commun Date: 2013 Impact factor: 14.919